Monoklonal gammopati med ubestemt signifikans

Niels Emil Ulrich Hermansen, Trine Silkjær, Charlotte Toftmann Hansen, Thomas Granum Aagaard, Henrik Gregersen

Publikation: Bidrag til tidsskriftReviewForskningpeer review


This review summarises the work-up of patients with monoclonal gammopathy of undetermined significance (MGUS). In persons above 70 years of age, around 5% have MGUS, a premalignant state with a monoclonal plasma immunoglobulin or light chain (M protein) in blood and/or urine. Continuous follow-up is recommended due to a risk of malignant progression of around 1% per year. Immunoglobulin M MGUS primarily progresses to Waldenström's macroglobulinaemia, whereas non-immunoglobulin M MGUS typically progresses to multiple myeloma or amyloid light-chain amyloidosis. Treatment is unnecessary unless in rare cases of severe non-malignant complications. Screening is not advised.

Bidragets oversatte titelMonoclonal gammopathy of undetermined significance
Sider (fra-til)1861-1865
Antal sider5
TidsskriftUgeskrift for laeger
Udgave nummer20
StatusUdgivet - 12 okt. 2020


Udforsk hvilke forskningsemner 'Monoklonal gammopati med ubestemt signifikans' indeholder.